MedTrace Logo

Smoking Cessation in the Surgical Pathway Before Major Lung Surgery

NCT04190966 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2020-01-06

No results posted yet for this study

Summary

This is a feasibility study of a personalised, integrated smoking cessation in the surgical pathway in patients undergoing major elective thoracic surgery when compared to usual care of standard community/hospital based NHS smoking cessation. Half the patients will receive the intervention and half the patients will receive usual care.

Conditions

  • Smoking Cessation
  • Thoracic Surgery

Interventions

BEHAVIORAL

Integrated Behavioural therapy

Integrated smoking cessation behavioural therapy

DRUG

Integrated Pharmacotherapy

Integrated smoking cessation pharmacotherapy including choice of combination nicotine replacement therapy, varenicline or electronic cigarettes

DEVICE

Integrated Web-based application

Integrated smoking cessation web-based application

Sponsors & Collaborators

  • University College, London

    collaborator OTHER

  • University of Birmingham

    lead OTHER

Principal Investigators

  • Babu Naidu, MD · University of Birmingham

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-31
Primary Completion
2021-07-31
Completion
2021-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04190966 on ClinicalTrials.gov